These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 26764419

  • 21. Biological variability of plasma intact and C-terminal FGF23 measurements.
    Smith ER, Cai MM, McMahon LP, Holt SG.
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
    [Abstract] [Full Text] [Related]

  • 22. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K, Nagano N, Tsuchiya K.
    Nephron Clin Pract; 2014 Sep; 128(1-2):1-10. PubMed ID: 25402964
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.
    Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM.
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E352-7. PubMed ID: 20685863
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts.
    Kanai T, Shiizaki K, Betsui H, Aoyagi J, Yamagata T.
    CEN Case Rep; 2018 Nov; 7(2):259-263. PubMed ID: 29767399
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients.
    Bleskestad IH, Thorsen IS, Jonsson G, Skadberg Ø, Bergrem H, Gøransson LG.
    Eur J Endocrinol; 2015 Apr; 172(4):343-50. PubMed ID: 25572388
    [Abstract] [Full Text] [Related]

  • 32. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C, Ljunggren Ö, Nilsson-Ehle H, Karlsson MK, Herlitz H, Lorentzon M, Ohlsson C, Mellström D.
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [Abstract] [Full Text] [Related]

  • 33. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH, Wai YY, Van YH, Lo FS.
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [Abstract] [Full Text] [Related]

  • 34. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.